Series B Completed
ENA Respiratory Series B
US$22.4m raised
Announced 20 Oct 2025
Investors
Investors
- Brandon Capital Partners · Existing investor
- Uniseed · Existing investor
- Stoic Venture Capital
- Gates Foundation
- Flu Lab
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- ENA Respiratory
- Stage
- Series B
- Amount raised
- US$22.4m
- Company based in
- Australia
Similar rounds
- Heidi Series B Oct 2025 · A$100m · led by Point72
- RelevanceAI Series B May 2025 · A$38.3m · led by Bessemer Venture Partners
- Lumonus A$28m round Nov 2025 · A$28m · led by Aviron Investment Management
- Agentio Series B Nov 2025 · A$61.1m · led by Forerunner Ventures
- ProcurePro Series B May 2026 · A$15m · led by QIC Ventures
Sources
- 27 Oct 2025 ENA Respiratory attracts US$22.4m (AU$34m) to fund Phase II clinical studies brandoncapital.vc
- 27 Oct 2025 ENA Respiratory Attracts US$22.4m (AU$34m) to Fund Phase II Clinical Studies of INNA-051 brandonbiocatalyst.com